Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.08.2012 | Case report

Glatiramer acetate/interferon-β-1b

Anaphylaxis, then depression with aggression and irritability: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Baumgartner A, Rauer S.Complete and long-lasting resolution of mild depressive symptoms after therapy interruption for eight weeks during interferon beta-1b Treatment. Aktuelle Neurologie, Supplement 39 (Suppl. 1): S34-S36, No. 1, Jan 2012. Available from: URL: http://dx.doi.org/10.1055/s-0032-1304882 - Germany Baumgartner A, Rauer S.Complete and long-lasting resolution of mild depressive symptoms after therapy interruption for eight weeks during interferon beta-1b Treatment. Aktuelle Neurologie, Supplement 39 (Suppl. 1): S34-S36, No. 1, Jan 2012. Available from: URL: http://​dx.​doi.​org/​10.​1055/​s-0032-1304882 - Germany
Metadaten
Titel
Glatiramer acetate/interferon-β-1b
Anaphylaxis, then depression with aggression and irritability: case report
Publikationsdatum
01.08.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214140-00087

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Amiodarone